Genmab | GEN - Crediti Commerciali

Prezzo Delle Azioni
1,679.00
Cambio Giornaliero
-11.00 -0.65%
Mensile
-4.14%
Annuale
18.11%
Q2 Previsione
1,628.53




Crediti Commerciali Cambiamento Data
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Almirall EUR 175.93M 17.87M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.57B 1.08B 2025-12
argenx SE USD 1.2B 289.13M 2025-06
AstraZeneca USD 17.88B 1.17B 2026-03
Bayer EUR 14.19B 720M 2025-12
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Demant DKK 5.5B 262M 2025-12
Exelixis USD 286.92M 24.38M 2025-12
Fresenius Medical Care EUR 3.66B 382.33M 2025-12
Galapagos EUR 199.75M 122.08M 2025-12
Genmab DKK 1.17B 119M 2025-12
GlaxoSmithKline GBP 7.94B 178M 2026-03
GN Store Nord DKK 5.29B 100M 2025-12
GRIFOLS EUR 852M 244.52M 2025-12
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Lonza CHF 1.78B 55M 2025-12
Merck EUR 4.44B 293M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12